|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Change in fair value of common stock warrant liability | |||||
| Interest income and financing expenses, net | |||||
| Pre-tax loss | |||||
| Income tax benefit | |||||
| Net loss and comprehensive loss | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Net loss per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
Loading...
